Background:

Catalyzes the hydrolytic deamination of enamine/imine intermediates that form during the course of normal metabolism. May facilitate the release of ammonia from these potentially toxic reactive metabolites, reducing their impact on cellular components. It may act on enamine/imine intermediates formed by several types of pyridoxal-5'-phosphate-dependent dehydratases including L-threonine dehydratase. May also function as an endoribonuclease, cleaving mRNA phosphodiester bonds of single-stranded RNA (By similarity). Thereby, may inhibit protein translation (PubMed:8973653).

Applications:

ELISA, WB, IHC

Name of antibody:

RIDA

Immunogen:

Fusion protein of human RIDA

Full name:

reactive intermediate imine deaminase A homolog

Synonyms:

PSP; P14.5; UK114; HRSP12; hp14.5

SwissProt:

P52758

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human lung cancer and Human liver cancer

IHC Recommend dilution:

50-200

WB Predicted band size:

14 kDa

WB Positive control:

Rat kidney tissue, Mouse liver tissue and Human fetal liver tissue lysates

WB Recommended dilution:

500-2000